| Literature DB >> 27846380 |
Evan Bailey1, Ye Cui2, Alicia Casey1, Joan M Stoler3, Xingbin Ai2, Dongdong Ma4, Robert Handin4, Piotr Sliz5, Sara O Vargas6, Souheil Y El-Chemaly7.
Abstract
Vascular endothelial growth factor (VEGF)-D is capable of inducing angiogenesis and lymphangiogenesis through signaling via VEGF receptor (VEGFR)-2 and VEGFR-3, respectively. Mutations in the FIGF (c-fos-induced growth factor) gene encoding VEGF-D have not been reported previously. We describe a young male with a hemizygous mutation in the X-chromosome gene FIGF (c.352 G>A) associated with early childhood respiratory deficiency. Histologically, lungs showed ectatic pulmonary arteries and pulmonary veins. The mutation resulted in a substitution of valine to methionine at residue 118 of the VEGF-D protein. The resultant mutant protein had increased dimerization, induced elevated VEGFR-2 signaling, and caused aberrant angiogenesis in vivo. Our observations characterize a new subtype of congenital diffuse lung disease, provide a histological correlate, and support a critical role for VEGF-D in lung vascular development and homeostasis.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27846380 PMCID: PMC5225300 DOI: 10.1016/j.ajpath.2016.09.008
Source DB: PubMed Journal: Am J Pathol ISSN: 0002-9440 Impact factor: 4.307